Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain

OBJECTIVE: According to a recent randomized, double-blind clinical trial comparing the combination of voriconazole and anidulafungin (VOR+ANI) with VOR monotherapy for invasive aspergillosis (IA) in patients with hematologic disease or with hematopoietic stem cell transplant, mortality was lower aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Grau, Santiago, Azanza, Jose Ramon, Ruiz, Isabel, Vallejo, Carlos, Mensa, Josep, Maertens, Johan, Heinz, Werner J, Barrueta, Jon Andoni, Peral, Carmen, Mesa, Francisco Jesús, Barrado, Miguel, Charbonneau, Claudie, Rubio-Rodríguez, Darío, Rubio-Terrés, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221484/
https://www.ncbi.nlm.nih.gov/pubmed/28115858
http://dx.doi.org/10.2147/CEOR.S122177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221484/
https://www.ncbi.nlm.nih.gov/pubmed/28115858
http://dx.doi.org/10.2147/CEOR.S122177

Ejemplares similares